Leerink Partnrs Has Positive Outlook of CRSP FY2025 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Leerink Partnrs increased their FY2025 earnings per share estimates for CRISPR Therapeutics in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings of ($5.16) per share for the year, up from their […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Leerink Partnrs increased their FY2025 earnings per share estimates for CRISPR Therapeutics in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings of ($5.16) per share for the year, up from their […]
